TreeWAS – Variant ID: rs1994090

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
B07 Viral warts	0.000	0.935	0.065
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.000	0.961	0.039
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.000	0.965	0.035
B08.1 Molluscum contagiosum	0.000	0.968	0.032
B00 Herpesviral [herpes simplex] infections	0.000	0.970	0.030
B02 Zoster [herpes zoster]	0.000	0.971	0.029
B06 Rubella [German measles]	0.000	0.972	0.028
B05 Measles	0.000	0.972	0.028
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.000	0.972	0.028
B04 Monkeypox	0.000	0.972	0.028
B03 Smallpox	0.000	0.972	0.028
B02.3 Zoster ocular disease	0.000	0.973	0.027
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.000	0.975	0.025
B08.5 Enteroviral vesicular pharyngitis	0.000	0.975	0.025
B08.4 Enteroviral vesicular stomatitis with exanthem	0.000	0.975	0.025
B08.3 Erythema infectiosum [fifth disease]	0.000	0.975	0.025
B08.2 Exanthema subitum [sixth disease]	0.000	0.975	0.025
B08.0 Other orthopoxvirus infections	0.000	0.975	0.025
B00.8 Other forms of herpesviral infection	0.000	0.975	0.025
B00.5 Herpesviral ocular disease	0.000	0.976	0.024
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.000	0.977	0.023
B00.1 Herpesviral vesicular dermatitis	0.000	0.978	0.022
B00.7 Disseminated herpesviral disease	0.000	0.978	0.022
B01 Varicella [chickenpox]	0.000	0.978	0.021
B00.3 Herpesviral meningitis	0.000	0.979	0.021
D25.1 Intramural leiomyoma of uterus	0.021	0.979	0.000
B02.7 Disseminated zoster	0.000	0.979	0.021
B02.0 Zoster encephalitis	0.000	0.979	0.021
B05.9 Measles without complication	0.000	0.980	0.020
B05.8 Measles with other complications	0.000	0.980	0.020
B05.4 Measles with intestinal complications	0.000	0.980	0.020
B05.3 Measles complicated by otitis media	0.000	0.980	0.020
B05.2 Measles complicated by pneumonia	0.000	0.980	0.020
B05.1 Measles complicated by meningitis	0.000	0.980	0.020
B05.0 Measles complicated by encephalitis	0.000	0.980	0.020
B06.9 Rubella without complication	0.000	0.980	0.020
B06.8 Rubella with other complications	0.000	0.980	0.020
B06.0 Rubella with neurological complications	0.000	0.980	0.020
B00.9 Herpesviral infection, unspecified	0.000	0.980	0.020
B00.0 Eczema herpeticum	0.000	0.980	0.020
B02.1 Zoster meningitis	0.000	0.981	0.019
B02.8 Zoster with other complications	0.000	0.981	0.019
B00.4 Herpesviral encephalitis	0.000	0.982	0.018
B02.2 Zoster with other nervous system involvement	0.000	0.984	0.016
B01.9 Varicella without complications	0.000	0.984	0.016
B02.9 Zoster without complication	0.000	0.984	0.016
B01.1 Varicella encephalitis	0.000	0.984	0.015
B01.0 Varicella meningitis	0.000	0.985	0.014
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.985	0.015
B01.2 Varicella pneumonia	0.000	0.986	0.013
B01.8 Varicella with other complications	0.000	0.986	0.013
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.987	0.013
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.988	0.011
D89.1 Cryoglobulinaemia	0.000	0.990	0.010
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.990	0.009
D89.3 Immune reconstitution syndrome	0.000	0.991	0.009
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.991	0.009
D80-D89 Certain disorders involving the immune mechanism	0.000	0.992	0.008
D86 Sarcoidosis	0.000	0.992	0.008
I44.2 Atrioventricular block, complete	0.008	0.992	0.000
D86.8 Sarcoidosis of other and combined sites	0.000	0.992	0.008
D86.0 Sarcoidosis of lung	0.000	0.992	0.008
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.993	0.007
D82 Immunodeficiency associated with other major defects	0.000	0.994	0.006
D80 Immunodeficiency with predominantly antibody defects	0.000	0.994	0.006
D86.3 Sarcoidosis of skin	0.000	0.994	0.006
D81 Combined immunodeficiencies	0.000	0.994	0.006
D75.1 Secondary polycythaemia	0.000	0.994	0.006
D86.9 Sarcoidosis, unspecified	0.000	0.994	0.006
I24.9 Acute ischaemic heart disease, unspecified	0.000	0.994	0.006
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.994	0.005
D84 Other immunodeficiencies	0.000	0.994	0.005
D83 Common variable immunodeficiency	0.000	0.995	0.005
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.995	0.005
D82.1 Di George's syndrome	0.000	0.995	0.005
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.995	0.005
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.995	0.005
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.995	0.005
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.995	0.005
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.995	0.005
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.995	0.005
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.995	0.005
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.995	0.005
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.995	0.005
D82.2 Immunodeficiency with short-limbed stature	0.000	0.995	0.005
D82.0 Wiskott-Aldrich syndrome	0.000	0.995	0.005
D81.9 Combined immunodeficiency, unspecified	0.000	0.995	0.004
D81.8 Other combined immunodeficiencies	0.000	0.995	0.004
D81.7 Major histocompatibility complex class II deficiency	0.000	0.995	0.004
D81.6 Major histocompatibility complex class I deficiency	0.000	0.995	0.004
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.995	0.004
D81.4 Nezelof's syndrome	0.000	0.995	0.004
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.995	0.004
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.995	0.004
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.995	0.004
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.995	0.004
D86.1 Sarcoidosis of lymph nodes	0.000	0.995	0.004
C43.5 Malignant melanoma of trunk	0.000	0.995	0.005
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.995	0.004
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.995	0.004
U51.1 Previously admitted to a psychiatric hospital of the provider	0.000	0.996	0.004
I78.1 Naevus, nonneoplastic	0.004	0.996	0.000
H52.2 Astigmatism	0.004	0.996	0.000
M47.86 Other spondylosis (Lumbar region)	0.000	0.996	0.004
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.996	0.004
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.996	0.004
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.996	0.004
S40.9 Superficial injury of shoulder and upper arm, unspecified	0.004	0.996	0.000
D83.8 Other common variable immunodeficiencies	0.000	0.996	0.004
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.996	0.004
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.996	0.004
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.996	0.004
D84.1 Defects in the complement system	0.000	0.996	0.004
D84.8 Other specified immunodeficiencies	0.000	0.996	0.004
K75.4 Autoimmune hepatitis	0.004	0.996	0.000
Y44.2 Anticoagulants	0.000	0.996	0.004
K75.9 Inflammatory liver disease, unspecified	0.004	0.996	0.000
D25.2 Subserosal leiomyoma of uterus	0.004	0.996	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.004	0.996	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.996	0.004
I78 Diseases of capillaries	0.004	0.996	0.000
M16.9 Coxarthrosis, unspecified	0.004	0.996	0.000
U51 Admission status on psychiatric patients	0.000	0.996	0.004
Z98.8 Other specified postsurgical states	0.000	0.996	0.004
D25 Leiomyoma of uterus	0.004	0.996	0.000
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.000	0.996	0.004
K75 Other inflammatory liver diseases	0.004	0.996	0.000
U51.0 Not Previously admitted to a psyciatric hospital	0.000	0.996	0.004
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.996	0.004
I78.0 Hereditary haemorrhagic telangiectasia	0.003	0.996	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
I78.8 Other diseases of capillaries	0.003	0.997	0.000
K75.0 Abscess of liver	0.003	0.997	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M06.9 Rheumatoid arthritis, unspecified	0.000	0.997	0.003
D83.9 Common variable immunodeficiency, unspecified	0.001	0.997	0.003
Q07.0 Arnold-Chiari syndrome	0.000	0.997	0.003
I78.9 Disease of capillaries, unspecified	0.003	0.997	0.000
U51.2 Previously admitted to a psychiatric hospital of another provider	0.000	0.997	0.003
Z29.1 Prophylactic immunotherapy	0.000	0.997	0.003
H61.0 Perichondritis of external ear	0.000	0.997	0.003
D35.1 Parathyroid gland	0.003	0.997	0.000
K75.8 Other specified inflammatory liver diseases	0.003	0.997	0.000
Z29 Need for other prophylactic measures	0.000	0.997	0.003
K75.2 Nonspecific reactive hepatitis	0.003	0.997	0.000
K75.1 Phlebitis of portal vein	0.003	0.997	0.000
O42.9 Premature rupture of membranes, unspecified	0.003	0.997	0.000
Z29.2 Other prophylactic chemotherapy	0.000	0.997	0.003
M23.31 Other meniscus derangements (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.997	0.003
K75.3 Granulomatous hepatitis, not elsewhere classified	0.003	0.997	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.997	0.003
E21.3 Hyperparathyroidism, unspecified	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
Z12.5 Special screening examination for neoplasm of prostate	0.003	0.997	0.000
I77.6 Arteritis, unspecified	0.003	0.997	0.000
Z29.8 Other specified prophylactic measures	0.000	0.997	0.003
Y44 Agents primarily affecting blood constituents	0.000	0.997	0.003
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.000	0.997	0.003
O36.6 Maternal care for excessive foetal growth	0.000	0.997	0.003
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.003	0.997	0.000
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.997	0.003
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.000	0.997	0.003
I24 Other acute ischaemic heart diseases	0.000	0.997	0.003
I24.1 Dressler's syndrome	0.000	0.997	0.002
I67.1 Cerebral aneurysm, nonruptured	0.000	0.997	0.002
S80.9 Superficial injury of lower leg, unspecified	0.002	0.998	0.000
H25.9 Senile cataract, unspecified	0.000	0.998	0.002
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.998	0.002
Z29.9 Prophylactic measure, unspecified	0.000	0.998	0.002
I72.4 Aneurysm of artery of lower extremity	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.998	0.002
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.000	0.998	0.002
I73.9 Peripheral vascular disease, unspecified	0.002	0.998	0.000
S27.0 Traumatic pneumothorax	0.002	0.998	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.000	0.998	0.002
Z29.0 Isolation	0.000	0.998	0.002
I77 Other disorders of arteries and arterioles	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.000	0.998	0.002
Y49.5 Other antipsychotics and neuroleptics	0.000	0.998	0.002
Y44.9 Other and unspecified agents affecting blood constituents	0.000	0.998	0.002
Y44.7 Plasma substitutes	0.000	0.998	0.002
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.000	0.998	0.002
Q07 Other congenital malformations of nervous system	0.000	0.998	0.002
I70.00 Atherosclerosis of aorta (without gangrene)	0.002	0.998	0.000
M47.89 Other spondylosis (Site unspecified)	0.002	0.998	0.000
D75 Other diseases of blood and blood-forming organs	0.000	0.998	0.002
Y44.6 Natural blood and blood products	0.000	0.998	0.002
I70-I79 Diseases of arteries, arterioles and capillaries	0.002	0.998	0.000
Q66.8 Other congenital deformities of feet	0.002	0.998	0.000
D35.2 Pituitary gland	0.002	0.998	0.000
Y44.5 Thrombolytic drugs	0.000	0.998	0.002
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.998	0.002
I77.8 Other specified disorders of arteries and arterioles	0.002	0.998	0.000
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.002	0.998	0.000
G54.0 Brachial plexus disorders	0.000	0.998	0.002
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.002	0.998	0.000
Z45.0 Adjustment and management of cardiac pacemaker	0.002	0.998	0.000
I77.3 Arterial fibromuscular dysplasia	0.002	0.998	0.000
Z48.8 Other specified surgical follow-up care	0.002	0.998	0.000
I24.8 Other forms of acute ischaemic heart disease	0.000	0.998	0.002
I72 Other aneurysm	0.002	0.998	0.000
I77.2 Rupture of artery	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.000	0.998	0.002
Q07.8 Other specified congenital malformations of nervous system	0.000	0.998	0.002
U80 Agent resistant to penicillin and related antibiotics	0.000	0.998	0.002
M06.34 Rheumatoid nodule (Hand)	0.000	0.998	0.002
U50 Level of care administered to neonates	0.000	0.998	0.002
U07 Emergency use of U07	0.000	0.998	0.002
U06 Emergency use of U06	0.000	0.998	0.002
U04 Severe acute respiratory syndrome [SARS]	0.000	0.998	0.002
U52 First in a series of a regular day/night admissions	0.000	0.998	0.002
I72.0 Aneurysm of carotid artery	0.002	0.998	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.002	0.998	0.000
M23.03 Cystic meniscus (Medial collateral ligament or Other and unspecified medial meniscus)	0.000	0.998	0.002
I70.0 Atherosclerosis of aorta	0.002	0.998	0.000
I77.5 Necrosis of artery	0.002	0.998	0.000
I77.4 Coeliac artery compression syndrome	0.002	0.998	0.000
Z45.1 Adjustment and management of infusion pump	0.002	0.998	0.000
M06.36 Rheumatoid nodule (Lower leg)	0.000	0.998	0.002
L98.4 Chronic ulcer of skin, not elsewhere classified	0.002	0.998	0.000
M23.30 Other meniscus derangements (Multiple sites)	0.000	0.998	0.002
Y49 Psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
I72.2 Aneurysm of renal artery	0.002	0.998	0.000
I77.0 Arteriovenous fistula, acquired	0.002	0.998	0.000
Q07.9 Congenital malformation of nervous system, unspecified	0.000	0.998	0.002
I74 Arterial embolism and thrombosis	0.002	0.998	0.000
M23.04 Cystic meniscus (Lateral collateral ligament or Anterior horn of lateral meniscus)	0.000	0.998	0.002
O41.8 Other specified disorders of amniotic fluid and membranes	0.000	0.998	0.002
U81 Agent resistant to vancomycin and related antibiotics	0.000	0.998	0.002
M06.37 Rheumatoid nodule (Ankle and foot)	0.000	0.998	0.002
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.000	0.998	0.002
C57.0 Fallopian tube	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.998	0.002
Z12.9 Special screening examination for neoplasm, unspecified	0.002	0.998	0.000
Z12.4 Special screening examination for neoplasm of cervix	0.002	0.998	0.000
M06 Other rheumatoid arthritis	0.000	0.998	0.002
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.000	0.998	0.002
D75.9 Disease of blood and blood-forming organs, unspecified	0.000	0.998	0.002
I77.9 Disorder of arteries and arterioles, unspecified	0.002	0.998	0.000
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.002	0.998	0.000
I79.1 Aortitis in diseases classified elsewhere	0.002	0.998	0.000
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.002	0.998	0.000
U80.0 Penicillin resistant agent	0.000	0.998	0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.002
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.002	0.998	0.000
Z12 Special screening examination for neoplasms	0.002	0.998	0.000
D75.0 Familial erythrocytosis	0.000	0.998	0.002
H40.5 Glaucoma secondary to other eye disorders	0.002	0.998	0.000
U81.8 Agent resistant to other vancomycin-related antibiotic	0.000	0.998	0.002
Y46.7 Anti-Parkinsonism drugs	0.000	0.998	0.002
Y49.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
M06.32 Rheumatoid nodule (Upper arm)	0.000	0.998	0.002
M54.19 Radiculopathy (Site unspecified)	0.000	0.998	0.002
I22.1 Subsequent myocardial infarction of inferior wall	0.002	0.998	0.000
I72.6 Aneurysm and dissection of vertebral artery	0.002	0.998	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.000	0.998	0.002
M06.39 Rheumatoid nodule (Site unspecified)	0.000	0.998	0.002
M06.38 Rheumatoid nodule (Other)	0.000	0.998	0.002
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.000	0.998	0.002
M06.31 Rheumatoid nodule (Shoulder region)	0.000	0.998	0.002
T86.8 Failure and rejection of other transplanted organs and tissues	0.002	0.998	0.000
D35 Benign neoplasm of other and unspecified endocrine glands	0.002	0.998	0.000
I70 Atherosclerosis	0.002	0.998	0.000
U04.9 Severe acute respiratory syndrome [SARS], unspecified	0.000	0.998	0.001
U06.9 Emergency use of U06.9	0.000	0.998	0.001
U06.8 Emergency use of U06.8	0.000	0.998	0.001
U06.7 Emergency use of U06.7	0.000	0.998	0.001
U06.6 Emergency use of U06.6	0.000	0.998	0.001
U06.5 Emergency use of U06.5	0.000	0.998	0.001
U06.4 Emergency use of U06.4	0.000	0.998	0.001
U06.3 Emergency use of U06.3	0.000	0.998	0.001
U06.2 Emergency use of U06.2	0.000	0.998	0.001
U06.1 Emergency use of U06.1	0.000	0.998	0.001
U06.0 Emergency use of U06.0	0.000	0.998	0.001
U07.9 Emergency use of U07.9	0.000	0.998	0.001
U07.8 Emergency use of U07.8	0.000	0.998	0.001
U07.7 Emergency use of U07.7	0.000	0.998	0.001
U07.6 Emergency use of U07.6	0.000	0.998	0.001
U07.5 Emergency use of U07.5	0.000	0.998	0.001
U07.4 Emergency use of U07.4	0.000	0.998	0.001
U07.3 Emergency use of U07.3	0.000	0.998	0.001
U07.2 Emergency use of U07.2	0.000	0.998	0.001
U07.1 Emergency use of U07.1	0.000	0.998	0.001
U07.0 Emergency use of U07.0	0.000	0.998	0.001
U50.9 Inquest Adjourned Death	0.000	0.998	0.001
U50.3 Level of care administered to neonates (Maximal Intensive Care)	0.000	0.998	0.001
U50.2 Level of care administered to neonates (High Dependancy Intensive Care)	0.000	0.998	0.001
U50.1 Level of care administered to neonates (Special Care)	0.000	0.998	0.001
U50.0 Level of care administered to neonates (Normal Care)	0.000	0.998	0.001
Y46.2 Hydantoin derivatives	0.000	0.998	0.002
Y49.2 Other and unspecified antidepressants	0.000	0.998	0.002
Z35.0 Supervision of pregnancy with history of infertility	0.002	0.998	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.001	0.998	0.000
I72.1 Aneurysm of artery of upper extremity	0.001	0.998	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.000	0.998	0.002
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.998	0.002
O46.9 Antepartum haemorrhage, unspecified	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.000	0.998	0.001
Y49.7 Psychostimulants with abuse potential	0.000	0.998	0.001
Y49.6 Psychodysleptics [hallucinogens]	0.000	0.998	0.001
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.001
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.001
C92.1 Chronic myeloid leukaemia	0.002	0.998	0.000
D75.2 Essential thrombocytosis	0.000	0.998	0.002
I73 Other peripheral vascular diseases	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
Z21 Asymptomatic human immunodeficiency virus [HIV] infection status	0.000	0.998	0.002
M06.33 Rheumatoid nodule (Forearm)	0.000	0.998	0.001
C91.1 Chronic lymphocytic leukaemia	0.002	0.998	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.000	0.998	0.002
Y49.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.001
Z12.3 Special screening examination for neoplasm of breast	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.000	0.998	0.002
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.002	0.998	0.000
M06.2 Rheumatoid bursitis	0.000	0.998	0.001
M06.0 Seronegative rheumatoid arthritis	0.000	0.998	0.002
Z57.2 Occupational exposure to dust	0.000	0.998	0.002
Z75.1 Person awaiting admission to adequate facility elsewhere	0.000	0.998	0.002
M89.09 Algoneurodystrophy (Site unspecified)	0.000	0.998	0.001
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.000	0.998	0.001
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.001	0.998	0.000
L90.0 Lichen sclerosus et atrophicus	0.002	0.998	0.000
M06.1 Adult-onset Still's disease	0.000	0.998	0.001
N30.0 Acute cystitis	0.002	0.998	0.000
W10.8 Other specified place	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.001
Z20 Contact with and exposure to communicable diseases	0.000	0.998	0.001
Z20-Z29 Persons with potential health hazards related to communicable diseases	0.000	0.998	0.002
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.998	0.001
N95.1 Menopausal and female climacteric states	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.000	0.998	0.002
Z20.1 Contact with and exposure to tuberculosis	0.000	0.998	0.001
M06.8 Other specified rheumatoid arthritis	0.000	0.998	0.001
M23.3 Other meniscus derangements	0.000	0.998	0.002
Y42.4 Oral contraceptives	0.000	0.998	0.001
Z12.6 Special screening examination for neoplasm of bladder	0.001	0.998	0.000
N61 Inflammatory disorders of breast	0.000	0.998	0.002
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)	0.001	0.998	0.000
D35.9 Endocrine gland, unspecified	0.001	0.998	0.000
D35.8 Pluriglandular involvement	0.001	0.998	0.000
D35.7 Other specified endocrine glands	0.001	0.998	0.000
D35.6 Aortic body and other paraganglia	0.001	0.998	0.000
D35.5 Carotid body	0.001	0.998	0.000
D35.4 Pineal gland	0.001	0.998	0.000
D35.3 Craniopharyngeal duct	0.001	0.998	0.000
N36.2 Urethral caruncle	0.001	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.000	0.998	0.001
I70.9 Generalised and unspecified atherosclerosis	0.001	0.999	0.000
I72.9 Aneurysm of unspecified site	0.001	0.999	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.999	0.001
Y46.4 Iminostilbenes	0.000	0.999	0.001
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.001	0.999	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.001	0.999	0.000
I70.8 Atherosclerosis of other arteries	0.001	0.999	0.000
J95.8 Other postprocedural respiratory disorders	0.000	0.999	0.001
K86.1 Other chronic pancreatitis	0.001	0.999	0.000
M23.0 Cystic meniscus	0.000	0.999	0.001
O41.0 Oligohydramnios	0.000	0.999	0.001
O42.0 Premature rupture of membranes, onset of labour within 24 hours	0.001	0.999	0.000
S01.5 Open wound of lip and oral cavity	0.000	0.999	0.001
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.999	0.001
M23.09 Cystic meniscus (Unspecified ligament or Unspecified meniscus)	0.000	0.999	0.001
I74.8 Embolism and thrombosis of other arteries	0.001	0.999	0.000
I74.0 Embolism and thrombosis of abdominal aorta	0.001	0.999	0.000
Y46.5 Valproic acid	0.000	0.999	0.001
Z12.8 Special screening examination for neoplasm of other sites	0.001	0.999	0.000
Z24 Need for immunisation against certain single viral diseases	0.000	0.999	0.001
M23.35 Other meniscus derangements (Posterior horn of lateral meniscus)	0.000	0.999	0.001
M54.39 Sciatica (Site unspecified)	0.001	0.999	0.000
Y42.9 Other and unspecified hormone antagonists	0.000	0.999	0.001
Y45.5 4-Aminophenol derivatives	0.000	0.999	0.001
Y48 Anaesthetics and therapeutic gases	0.000	0.999	0.001
M54.37 Sciatica (Lumbosacral region)	0.001	0.999	0.000
S27.1 Traumatic haemothorax	0.001	0.999	0.000
Z20.8 Contact with and exposure to other communicable diseases	0.000	0.999	0.001
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.999	0.001
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.999	0.001
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.999	0.001
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.999	0.001
M06.28 Rheumatoid bursitis (Other)	0.000	0.999	0.001
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.999	0.001
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.999	0.001
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.999	0.001
M06.24 Rheumatoid bursitis (Hand)	0.000	0.999	0.001
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.999	0.001
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.999	0.001
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.999	0.001
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.999	0.001
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.001	0.999	0.000
R25.2 Cramp and spasm	0.001	0.999	0.000
Y46.8 Antispasticity drugs	0.000	0.999	0.001
Y46.3 Deoxybarbiturates	0.000	0.999	0.001
Y46.1 Oxazolidinediones	0.000	0.999	0.001
Y46.0 Succinimides	0.000	0.999	0.001
A63.0 Anogenital (venereal) warts	0.000	0.999	0.001
Z12.2 Special screening examination for neoplasm of respiratory organs	0.001	0.999	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.001	0.999	0.000
Z20.9 Contact with and exposure to unspecified communicable disease	0.000	0.999	0.001
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations	0.000	0.999	0.001
Z20.6 Contact with and exposure to human immunodeficiency virus [HIV]	0.000	0.999	0.001
Z20.5 Contact with and exposure to viral hepatitis	0.000	0.999	0.001
Z20.4 Contact with and exposure to rubella	0.000	0.999	0.001
Z20.3 Contact with and exposure to rabies	0.000	0.999	0.001
Z20.2 Contact with and exposure to infections with a predominantly sexual mode of transmission	0.000	0.999	0.001
Z20.0 Contact with and exposure to intestinal infectious diseases	0.000	0.999	0.001
Z28 Immunisation not carried out	0.000	0.999	0.001
Z27 Need for immunisation against combinations of infectious diseases	0.000	0.999	0.001
Z25 Need for immunisation against other single viral diseases	0.000	0.999	0.001
Z23 Need for immunisation against single bacterial diseases	0.000	0.999	0.001
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.999	0.001
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.999	0.001
M06.18 Adult-onset Still's disease (Other)	0.000	0.999	0.001
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.999	0.001
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.999	0.001
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.999	0.001
M06.14 Adult-onset Still's disease (Hand)	0.000	0.999	0.001
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.999	0.001
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.999	0.001
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.999	0.001
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.999	0.001
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.999	0.001
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.999	0.001
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.999	0.001
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.999	0.001
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.999	0.001
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.999	0.001
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.999	0.001
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.999	0.001
M85.87 Other specified disorders of bone density and structure (Ankle and foot)	0.001	0.999	0.000
I72.8 Aneurysm of other specified arteries	0.001	0.999	0.000
I74.5 Embolism and thrombosis of iliac artery	0.001	0.999	0.000
S40 Superficial injury of shoulder and upper arm	0.001	0.999	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.999	0.001
M23.37 Other meniscus derangements-Capsular lig	0.000	0.999	0.001
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.000	0.999	0.001
D75.8 Other specified diseases of blood and blood-forming organs	0.000	0.999	0.001
E21.5 Disorder of parathyroid gland, unspecified	0.001	0.999	0.000
I70.1 Atherosclerosis of renal artery	0.001	0.999	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.001	0.999	0.000
O21.9 Vomiting of pregnancy, unspecified	0.000	0.999	0.001
Z24.5 Need for immunisation against rubella alone	0.000	0.999	0.001
Y52 Agents primarily affecting the cardiovascular system	0.000	0.999	0.001
Z26 Need for immunisation against other single infectious diseases	0.000	0.999	0.001
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.001	0.999	0.000
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.999	0.001
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.999	0.001
M85.88 Other specified disorders of bone density and structure (Other)	0.001	0.999	0.000
M89.04 Algoneurodystrophy (Hand)	0.000	0.999	0.001
S22.00 Fracture of thoracic vertebra (closed)	0.001	0.999	0.000
K55.9 Vascular disorder of intestine, unspecified	0.000	0.999	0.001
U81.0 Vancomycin resistant agent	0.000	0.999	0.001
S27 Injury of other and unspecified intrathoracic organs	0.001	0.999	0.000
I70.81 Atherosclerosis of other arteries (with gangrene)	0.001	0.999	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.001	0.999	0.000
M23.07 Cystic meniscus-Capsular lig	0.000	0.999	0.001
M23.05 Cystic meniscus (Posterior horn of lateral meniscus)	0.000	0.999	0.001
M23.01 Cystic meniscus (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.999	0.001
M23.00 Cystic meniscus (Multiple sites)	0.000	0.999	0.001
M85.86 Other specified disorders of bone density and structure (Lower leg)	0.001	0.999	0.000
K86.0 Alcohol-induced chronic pancreatitis	0.001	0.999	0.000
O41 Other disorders of amniotic fluid and membranes	0.000	0.999	0.001
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.999	0.001
M23.02 Cystic meniscus (Posterior cruciate ligament or Posterior horn of medial meniscus)	0.000	0.999	0.001
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.000	0.999	0.001
M85.81 Other specified disorders of bone density and structure (Shoulder region)	0.001	0.999	0.000
I73.1 Thromboangiitis obliterans [Buerger]	0.001	0.999	0.000
M89.0 Algoneurodystrophy	0.000	0.999	0.001
O41.1 Infection of amniotic sac and membranes	0.000	0.999	0.001
Y48.5 Therapeutic gases	0.000	0.999	0.001
Y48.1 Parenteral anaesthetics	0.000	0.999	0.001
Y48.0 Inhaled anaesthetics	0.000	0.999	0.001
Y52.1 Calcium-channel blockers	0.000	0.999	0.001
Z24.6 Need for immunisation against viral hepatitis	0.000	0.999	0.001
Z24.4 Need for immunisation against measles alone	0.000	0.999	0.001
Z24.3 Need for immunisation against yellow fever	0.000	0.999	0.001
Z24.2 Need for immunisation against rabies	0.000	0.999	0.001
Z24.1 Need for immunisation against arthropod-borne viral encephalitis	0.000	0.999	0.001
Z24.0 Need for immunisation against poliomyelitis	0.000	0.999	0.001
N10 Acute tubulo-interstitial nephritis	0.001	0.999	0.000
O42 Premature rupture of membranes	0.001	0.999	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.999	0.001
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.999	0.001
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.999	0.001
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)	0.001	0.999	0.000
E21.4 Other specified disorders of parathyroid gland	0.001	0.999	0.000
I15.1 Hypertension secondary to other renal disorders	0.001	0.999	0.000
I42.8 Other cardiomyopathies	0.001	0.999	0.000
N02.8 Other	0.000	0.999	0.001
I70.80 Atherosclerosis of other arteries (without gangrene)	0.001	0.999	0.000
S72.10 Pertrochanteric fracture (closed)	0.001	0.999	0.000
E21.2 Other hyperparathyroidism	0.001	0.999	0.000
E21.0 Primary hyperparathyroidism	0.001	0.999	0.000
G44.0 Cluster headache syndrome	0.000	0.999	0.001
Q66.2 Metatarsus varus	0.001	0.999	0.000
Z23.8 Need for immunisation against other single bacterial diseases	0.000	0.999	0.001
Z23.7 Need for immunisation against pertussis alone	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations